Steroid-eluting leads revolutionized cardiac pacing by enabling reliable, low stimulation thresholds at the electrode-tissue interface.
Supports steroid-eluting leads for reliable low thresholds; leaves open optimal designs for next-generation devices.
The electrode‐tissue interface is that area lying between the cathode of a low‐voltage implantable pacemaker or cardioverter‐defibrillator (ICD) lead and the endocardium or epi‐myocardium of the cardiac chamber being paced. The electrical stimulus that is delivered to this interface is responsible for myocyte depolarization with consequent cardiac contraction. The process by which this occurs is reasonably well understood and any explanation requires a basic understanding of the physics and cellular electrophysiology of pacing. The effective and efficient delivery of electrical energy to the myocardium via the lead is dependent on many factors to be discussed in this review. However, despite numerous evolutionary changes occurring in the cathode's material, design, and surface configuration, it was not until the incorporation of steroid‐elution to the electrode‐tissue interface that reliable and significantly low stimulation threshold cardiac pacing became possible.
No takes yet. Share an insight, caveat, or question.
Mond et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: